Russell Investments Group’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$469K Sell
42,491
-5,568
-12% -$61.4K ﹤0.01% 2360
2025
Q1
$429K Buy
48,059
+26,069
+119% +$233K ﹤0.01% 2346
2024
Q4
$207K Sell
21,990
-25,108
-53% -$236K ﹤0.01% 2533
2024
Q3
$380K Sell
47,098
-3,420
-7% -$27.6K ﹤0.01% 2352
2024
Q2
$428K Buy
50,518
+5,404
+12% +$45.8K ﹤0.01% 2254
2024
Q1
$405K Buy
45,114
+16,135
+56% +$145K ﹤0.01% 2267
2023
Q4
$326K Sell
28,979
-17,524
-38% -$197K ﹤0.01% 2328
2023
Q3
$401K Sell
46,503
-7,115
-13% -$61.4K ﹤0.01% 2301
2023
Q2
$555K Sell
53,618
-19,236
-26% -$199K ﹤0.01% 2192
2023
Q1
$790K Buy
72,854
+83
+0.1% +$901 ﹤0.01% 2082
2022
Q4
$816K Buy
72,771
+13,801
+23% +$155K ﹤0.01% 2073
2022
Q3
$596K Sell
58,970
-7,191
-11% -$72.7K ﹤0.01% 2173
2022
Q2
$598K Sell
66,161
-5,084
-7% -$46K ﹤0.01% 2197
2022
Q1
$680K Sell
71,245
-40,955
-37% -$391K ﹤0.01% 2130
2021
Q4
$1.24M Buy
112,200
+44,220
+65% +$488K ﹤0.01% 2044
2021
Q3
$501K Sell
67,980
-14,014
-17% -$103K ﹤0.01% 2458
2021
Q2
$1.19M Sell
81,994
-5,128
-6% -$74.4K ﹤0.01% 2230
2021
Q1
$1.78M Sell
87,122
-16,106
-16% -$328K ﹤0.01% 1938
2020
Q4
$1.83M Sell
103,228
-9,937
-9% -$176K ﹤0.01% 1803
2020
Q3
$1.67M Buy
113,165
+16,993
+18% +$251K ﹤0.01% 1800
2020
Q2
$2.02M Buy
96,172
+13,804
+17% +$289K ﹤0.01% 1629
2020
Q1
$1.9M Buy
82,368
+72,968
+776% +$1.69M ﹤0.01% 1493
2019
Q4
$243K Buy
+9,400
New +$243K ﹤0.01% 2642
2017
Q4
Sell
-18,508
Closed -$634K 3007
2017
Q3
$634K Sell
18,508
-2,957
-14% -$101K ﹤0.01% 2352
2017
Q2
$855K Buy
21,465
+6,777
+46% +$270K ﹤0.01% 2191
2017
Q1
$541K Hold
14,688
﹤0.01% 2392
2016
Q4
$464K Buy
+14,688
New +$464K ﹤0.01% 2491